๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Acute Leukemia
Clinical trial register · China

Acute Leukemia Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5 Suzhou 4 Chengdu 2 Guangzhou 2 Hangzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5 Suzhou4 Chengdu2 Guangzhou2 Hangzhou2
All 11 locations
Target enrolment
to

Acute Leukemia trials in China

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
BY002 IIT Study in R/R Acute Leukemia
NCT07270770Acute Leukemia, KMT2A Rearrangements or NPM1 Mutations Acute Leukemia
DrugBY002
The First Affiliated Hospital of Soochow University
Phase 1
18
Suzhou
2026-03-15
Recruiting
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
NCT07559695Menin Inhibitors, Acute Leukemia, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy
The First Affiliated Hospital of Soochow University
Observational
20
Suzhou
2025-11-01
Recruiting
Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)
NCT07362095Acute Leukemia
Zhujiang Hospital
Phase 1/2
46
Guangzhou
2025-10-01
Not yet open
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
NCT07087847Acute Leukemia, Acute Leukemia Refractory, Acute Myeloid Leukemia (AML), ALL (Acute B-Lymphoblastic Leukemia)
Ruijin Hospital
Not applicable
18
Shanghai
2025-09-01
Recruiting
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
NCT07101497Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy, Acute Leukemia
DrugBN104
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2025-08-01
Recruiting
Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT
NCT06984536Myelodysplastic Syndrome, Acute Leukemia
Peking University People's Hospital
Phase 2
40
Beijing
2025-05-21
Not yet open
The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults
NCT06876701Acute Leukemia
Ruijin Hospital
Phase EARLY_PHASE1
10
Shanghai
2025-04-01
Recruiting
The Effect of Serum Ferritin in irAE
NCT06702566Immune-related Adverse Event, Malignant Solid Tumors, Acute Leukemia, Serum Ferritin
Tianjin Medical University Cancer Institute and Hospital
Not applicable
1,500
Tianjin
2024-07-04
Recruiting
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemia
NCT06585345Acute-Leukemia
The General Hospital of Western Theater Command
Phase 1/2
200
Chengdu
2024-02-18
Recruiting
Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction
NCT06211166Acute Leukemia, MDS, MDS/MPN, CML
Peking University People's Hospital
Observational
300
Beijing
2024-01-08
Recruiting
Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
NCT05902416Acute Leukemia, Myelodysplastic Syndromes
Peking University People's Hospital
Observational
120
Beijing
2023-06-01
Recruiting
Olverembatinib for FGFR1-rearranged Neoplasms
NCT05521204Myeloproliferative Neoplasm, Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
20
Suzhou
2022-09-01
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
NCT04811560Acute Leukemia
Janssen Research & Development, LLC
Phase 1/2
420
Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing
2021-05-19
Recruiting
CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia
NCT04157569Acute Leukemia
Navy General Hospital, Beijing
Observational
200
Beijing
2019-11-05
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/acute-leukemia

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Acute Leukemia.

How many Acute Leukemia trials are recruiting in China?

13 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Acute Leukemia), 15 studies
PhaseStudiesRecruitingShare
Observational5533.3%
Phase 1/23320%
Phase 23320%
Not applicable2113.3%
Phase 1116.7%
Phase EARLY_PHASE1106.7%

Most active sponsors

Lead sponsors with the most studies (Acute Leukemia)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Soochow University44
Peking University People's Hospital33
Ruijin Hospital20
Janssen Research & Development, LLC11
Navy General Hospital, Beijing11
The General Hospital of Western Theater Command11
Tianjin Medical University Cancer Institute and Hospital11
Zhejiang University11
Zhujiang Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.